Open Access · Peer Reviewed
PDF
DOI

Keywords

Biomarkers, procalcitonin, recent advancement, novel antimicrobial therapies, antimicrobial therapies.

How to Cite

RECENT ADVANCEMENT IN THE MANAGEMENT OF PNEUMONIA. (2026). SYNAPSES: INSIGHTS ACROSS THE DISCIPLINES, 3(5), 133-142. https://www.universalpublishings.com/index.php/siad/article/view/18320

Abstract

Pneumonia is an infection in your lungs caused by bacteria, viruses or fungi. Pneumonia causes your lung tissue to swell (inflammation) and can cause fluid or pus in your lungs. Bacterial pneumonia is usually more severe than viral pneumonia, which often resolves on its own. Pneumonia can affect one or both lungs. Pneumonia in both of your lungs is called bilateral or double pneumonia.

PDF
DOI

References

REFERENCE

• Govindan, S.; Hyzy, R.C. The 2016 Guidelines for Hospital-acquired and Ventilator-associated Pneumonia

• Poole, S.; Clark, T.W. Rapid syndromic molecular testing in pneumonia: The current landscape and future potential. J. Infect 2020,80, 1–7

• Unyvero. Unyvero Lower Respiratory. Available online: https://www.opgen.com/wp-content/uploads/2022/04/PN3677D.pdf (accessed on 11 November 2024)

• High, J.; Enne, V.I.; Barber, J.A.; Brealey, D.; Turner, D.A.; Horne, R.; Peters, M.; Dhesi, Z.; Wagner, A.P.; Pandolfo, A.M.; et al.

• Niederman, M.S.; Torres, A. Severe community-acquired pneumonia. Eur. Respir. Rev. 2022,31, 220123

• Chahine, E.B.; Sucher, A.J. Lefamulin: The First Systemic Pleuromutilin Antibiotic. Ann. Pharmacother. 2020,54, 1203–1214.

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Indexed In · Partners

Trusted by Global Scientific Indexing Services

JUSR is indexed and recognized by leading international databases and research integrity organizations.